Pfizer, Inc. acquires NextWave Pharmaceuticals, Inc.

On November 28, 2012, Pfizer, Inc. acquired NextWave Pharmaceuticals, Inc., a life science company, from Bay City Capital LLC and Aisling Capital.

Deal at a glance

AnnouncedNovember 28, 2012 TypeAdd-on Acquistion TargetNextWave Pharmaceuticals, Inc. Buyer Pfizer, Inc. Sellers Bay City Capital LLC
Aisling Capital SectorLife Science ValueMembers only

Target company

NextWave Pharmaceuticals, Inc.

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Pfizer, Inc.

Company · 57 deals on record

16th transaction in life science

57deals, all time

32in this sector

2022latest

Sellers (2)

Bay City Capital LLC

Private equity firm · 78 deals on record

Aisling Capital

Private equity firm · 88 deals on record

78investments

51in this sector

53exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Biohaven Pharmaceutical Holding Co. Ltd.Same lead buyer · May 2022

ReViral Ltd.Same lead buyer · Apr 2022

Questions about this deal

Who acquired NextWave Pharmaceuticals, Inc.?Pfizer, Inc. acquired NextWave Pharmaceuticals, Inc. on November 28, 2012.

Who sold NextWave Pharmaceuticals, Inc.?Bay City Capital LLC and Aisling Capital were the sellers.

What type of deal was it?It was a add-on acquistion in the life science sector in 2012.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).